EverSource Wealth Advisors »

Galectin Therapeutics shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $326 77 4.23
2025-06-30 $339 161 2.11
2025-03-31 $24 20 1.20
2024-12-31 $58 46 1.28

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
iShares Gold Trust ETF Etf (IAU)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Microsoft Corp Stock (MSFT)
Tesla Stock (TSLA)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Total Stock Market Etf Etf (VTI)
Broadcom Stock (AVGO)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for EverSource Wealth Advisors

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
BlackRock
Geode Capital Management
Susquehanna International
Marshall Wace
Sontag Advisory
LPL Financial
Geneos Wealth Management
Commonwealth Equity Services
Vivaldi Capital Management
State Street Corporation
Morgan Stanley
Retirement Guys Formula
Sovran Advisors

View all funds holding Galectin Therapeutics